Medical information Clinical review pending

Genetic Testing

Myo16 Gene Autism Spectrum Disorder Myo16 Related Genetic Test

The Myo16 Gene Autism Spectrum Disorder Test uses Next-Generation Sequencing (NGS) to identify genetic variations in the MYO16 gene associated with autism spectrum disorders (ASD). This test can provide valuable insights for families seeking to understand potential genetic factors related to ASD.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Blood sample (EDTA tube). Confirm specific volume requirements with the laboratory before booking.
Results: Confirm turnaround time with the laboratory before booking.
Preparation: No special preparation is typically required for this test. However, confirm with the laboratory for any specific instructions.

Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Myo16 Gene Autism Spectrum Disorder Myo16 Related Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Individuals exhibiting symptoms consistent with autism spectrum disorder.
✓Children with developmental delays or neurological symptoms.
✓Families with a known history of autism spectrum disorder or related neurological conditions.
✓Individuals seeking genetic information to aid in diagnosis and management planning.
✓Family planning considerations where genetic risk is a concern.

In plain language

What this test helps you understand

This test identifies genetic variations in the MYO16 gene associated with autism spectrum disorders. It can aid in understanding potential genetic contributions to ASD in individuals presenting with relevant symptoms or family history.

The Myo16 Gene Autism Spectrum Disorder Test is a genetic test that employs Next-Generation Sequencing (NGS) technology. It is designed to detect specific genetic variations within the MYO16 gene, which research has linked to certain neurological conditions, including autism spectrum disorders (ASD). Understanding these genetic factors can be important for families navigating ASD diagnosis and management. This test focuses specifically on the MYO16 gene. Results are interpreted in conjunction with clinical findings and family history. Consult with a healthcare provider to determine if this test is appropriate.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo special preparation is typically required for this test. However, confirm with the laboratory for any specific instructions.

SampleBlood sample (EDTA tube). Confirm specific volume requirements with the laboratory before booking.

MethodologyNext-Generation Sequencing (NGS) is used to analyze the MYO16 gene for specific genetic variations.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test only analyzes the MYO16 gene. Autism spectrum disorder is complex and can be associated with variations in many other genes or environmental factors. A negative result does not rule out ASD or other genetic conditions. Results should be interpreted by a qualified healthcare professional.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

The MYO16 gene provides instructions for making a protein involved in brain development and function. Certain variations in this gene have been associated with an increased risk of developing neurological conditions, including autism spectrum disorder.

This test may be considered for individuals showing signs of autism spectrum disorder, children with developmental delays, or families with a history of ASD or related conditions. Discuss with your doctor if this test is appropriate for you.

A positive result indicates the presence of specific genetic variations in the MYO16 gene associated with ASD. It's important to discuss the implications of the result with a genetic counselor or doctor, as it is just one piece of the diagnostic puzzle.

A negative result means that the specific variations in the MYO16 gene tested for were not found. It does not rule out ASD, as other genetic or environmental factors may be involved. Consult your doctor for interpretation.

Results are typically provided through a detailed report sent to the ordering physician. A consultation with a genetic counselor or specialist is recommended to understand the findings.

Yes, home sample collection services are available in select locations, including Nairobi, Mombasa, and Kisumu. Please inquire about availability and booking procedures.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp